259 related articles for article (PubMed ID: 30013035)
1. Isoalantolactone suppresses LPS-induced inflammation by inhibiting TRAF6 ubiquitination and alleviates acute lung injury.
Ding YH; Song YD; Wu YX; He HQ; Yu TH; Hu YD; Zhang DP; Jiang HC; Yu KK; Li XZ; Sun L; Qian F
Acta Pharmacol Sin; 2019 Jan; 40(1):64-74. PubMed ID: 30013035
[TBL] [Abstract][Full Text] [Related]
2. Tabersonine attenuates lipopolysaccharide-induced acute lung injury via suppressing TRAF6 ubiquitination.
Zhang D; Li X; Hu Y; Jiang H; Wu Y; Ding Y; Yu K; He H; Xu J; Sun L; Qian F
Biochem Pharmacol; 2018 Aug; 154():183-192. PubMed ID: 29746822
[TBL] [Abstract][Full Text] [Related]
3. Isoalantolactone protects LPS-induced acute lung injury through Nrf2 activation.
Yuan CB; Tian L; Yang B; Zhou HY
Microb Pathog; 2018 Oct; 123():213-218. PubMed ID: 30009971
[TBL] [Abstract][Full Text] [Related]
4. Isoalantolactone inhibits LPS-induced inflammation via NF-κB inactivation in peritoneal macrophages and improves survival in sepsis.
He G; Zhang X; Chen Y; Chen J; Li L; Xie Y
Biomed Pharmacother; 2017 Jun; 90():598-607. PubMed ID: 28407580
[TBL] [Abstract][Full Text] [Related]
5. Kaempferol reduces K63-linked polyubiquitination to inhibit nuclear factor-κB and inflammatory responses in acute lung injury in mice.
Qian J; Chen X; Chen X; Sun C; Jiang Y; Qian Y; Zhang Y; Khan Z; Zhou J; Liang G; Zheng C
Toxicol Lett; 2019 May; 306():53-60. PubMed ID: 30769083
[TBL] [Abstract][Full Text] [Related]
6. Nodakenin suppresses lipopolysaccharide-induced inflammatory responses in macrophage cells by inhibiting tumor necrosis factor receptor-associated factor 6 and nuclear factor-κB pathways and protects mice from lethal endotoxin shock.
Rim HK; Cho W; Sung SH; Lee KT
J Pharmacol Exp Ther; 2012 Sep; 342(3):654-64. PubMed ID: 22637723
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of forsythoside B against lipopolysaccharide-induced acute lung injury by attenuating the TLR4/NF-κB pathway.
Liu JX; Li X; Yan FG; Pan QJ; Yang C; Wu MY; Li G; Liu HF
Int Immunopharmacol; 2019 Jan; 66():336-346. PubMed ID: 30521962
[TBL] [Abstract][Full Text] [Related]
8. β-Patchoulene from patchouli oil protects against LPS-induced acute lung injury via suppressing NF-κB and activating Nrf2 pathways.
Chen XY; Dou YX; Luo DD; Zhang ZB; Li CL; Zeng HF; Su ZR; Xie JH; Lai XP; Li YC
Int Immunopharmacol; 2017 Sep; 50():270-278. PubMed ID: 28711783
[TBL] [Abstract][Full Text] [Related]
9. Dehydrocostus Lactone Suppresses LPS-induced Acute Lung Injury and Macrophage Activation through NF-κB Signaling Pathway Mediated by p38 MAPK and Akt.
Nie Y; Wang Z; Chai G; Xiong Y; Li B; Zhang H; Xin R; Qian X; Tang Z; Wu J; Zhao P
Molecules; 2019 Apr; 24(8):. PubMed ID: 30999647
[TBL] [Abstract][Full Text] [Related]
10. Isoalantolactone alleviates ovalbumin‑induced asthmatic inflammation by reducing alternatively activated macrophage and STAT6/PPAR‑γ/KLF4 signals.
Song Y; Li X; Liu F; Zhu H; Shen Y
Mol Med Rep; 2021 Oct; 24(4):. PubMed ID: 34368878
[TBL] [Abstract][Full Text] [Related]
11. Trametinib alleviates lipopolysaccharide-induced acute lung injury by inhibiting the MEK-ERK-Egr-1 pathway.
Chen S; Xu H; Ye P; Wu C; Ding X; Chen S; Zhang H; Zou Y; Zhao J; Le S; Wu J; Chen S; Xia J
Int Immunopharmacol; 2020 Mar; 80():106152. PubMed ID: 31926447
[TBL] [Abstract][Full Text] [Related]
12. LFG-500, a newly synthesized flavonoid, attenuates lipopolysaccharide-induced acute lung injury and inflammation in mice.
Li C; Yang D; Cao X; Wang F; Jiang H; Guo H; Du L; Guo Q; Yin X
Biochem Pharmacol; 2016 Aug; 113():57-69. PubMed ID: 27206337
[TBL] [Abstract][Full Text] [Related]
13. Asiaticoside attenuates lipopolysaccharide-induced acute lung injury via down-regulation of NF-κB signaling pathway.
Qiu J; Yu L; Zhang X; Wu Q; Wang D; Wang X; Xia C; Feng H
Int Immunopharmacol; 2015 May; 26(1):181-7. PubMed ID: 25835778
[TBL] [Abstract][Full Text] [Related]
14. Novel clerodane-type diterpenoid Cintelactone A suppresses lipopolysaccharide -induced inflammation by promoting ubiquitination, proteasomal degradation of TRAF6.
Di Q; Zhao X; Zhang R; Ma X; Liang X; Li X; Gao J; Tang H; Chen W; Xiao W
Pharmacol Res; 2021 Feb; 164():105386. PubMed ID: 33352228
[TBL] [Abstract][Full Text] [Related]
15. Zerumbone from Zingiber zerumbet Ameliorates Lipopolysaccharide-Induced ICAM-1 and Cytokines Expression via p38 MAPK/JNK-IκB/NF-κB Pathway in Mouse Model of Acute Lung Injury.
Lee CY; Chen SP; Su CH; Ho YC; Yang ML; Lee SS; Huang-Liu R; Yang CP; Chen CJ; Kuan YH
Chin J Physiol; 2018 Jun; 61(3):171-180. PubMed ID: 29962177
[TBL] [Abstract][Full Text] [Related]
16. Natural molecule Munronoid I attenuates LPS-induced acute lung injury by promoting the K48-linked ubiquitination and degradation of TAK1.
Ma X; Li X; Di Q; Zhao X; Zhang R; Xiao Y; Sun P; Tang H; Quan J; Xiao W; Chen W
Biomed Pharmacother; 2021 Jun; 138():111543. PubMed ID: 34311538
[TBL] [Abstract][Full Text] [Related]
17. Protostemonine alleviates heat-killed methicillin-resistant Staphylococcus aureus-induced acute lung injury through MAPK and NF-κB signaling pathways.
Wu Y; Nie Y; Huang J; Qiu Y; Wan B; Liu G; Chen J; Chen D; Pang Q
Int Immunopharmacol; 2019 Dec; 77():105964. PubMed ID: 31669889
[TBL] [Abstract][Full Text] [Related]
18. The STAT3 inhibitor B9 alleviates lipopolysaccharide-induced acute lung injury through its anti-inflammatory effects.
Cao L; Song H; Zhou S; Lan K; Lv K; Huang M
Int Immunopharmacol; 2024 Jun; 135():112221. PubMed ID: 38762924
[TBL] [Abstract][Full Text] [Related]
19. Genipin alleviates LPS-induced acute lung injury by inhibiting NF-κB and NLRP3 signaling pathways.
Zhang A; Wang S; Zhang J; Wu H
Int Immunopharmacol; 2016 Sep; 38():115-9. PubMed ID: 27262946
[TBL] [Abstract][Full Text] [Related]
20.
Ma Q; Wang K; Yang Q; Ping S; Zhao W; Shou Q; Zhou W; Chen M
Mediators Inflamm; 2016; 2016():7934049. PubMed ID: 27890971
[No Abstract] [Full Text] [Related]
[Next] [New Search]
